United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news TransDigm (NYSE: TDG) to deepen aerospace electronics play with Stellant acquisition Find out why TransDigm is spending $960M on Stellant Systems and what this means for defense electronics and aftermarket strategy going forward. bySrinathDecember 31, 2025